{"DataElement":{"publicId":"1538","version":"3","preferredName":"Prostate Tumor Histologic Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis.\r\n","longName":"PRS_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188806","version":"1","preferredName":"Prostate Tumor Histologic Classification","preferredDefinition":"information related to histologic classification for a prostate tumor.","longName":"PRS_TUMOR_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E564D9BA-7E8E-2B5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018427","version":"1","preferredName":"Prostate Tumor Histologic Category","preferredDefinition":"the histologic type of a prostate tumor.","longName":"PRS_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenocarcinoma, conventional NOS","valueDescription":"ADENOCARCINOMA, CONVENTIONAL, NOT OTHERWISE SPECIFIED","ValueMeaning":{"publicId":"2558179","version":"1","preferredName":"ADENOCARCINOMA, CONVENTIONAL, NOT OTHERWISE SPECIFIED","longName":"2558179","preferredDefinition":"ADENOCARCINOMA, CONVENTIONAL, NOT OTHERWISE SPECIFIED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B050-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662E1C-9A2F-40FF-E034-0003BA12F5E7","beginDate":"2004-06-21","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Adenocarcinoma/Acinar","valueDescription":"ADENOCARCINOMA/ACINAR","ValueMeaning":{"publicId":"2558181","version":"1","preferredName":"ADENOCARCINOMA/ACINAR","longName":"2558181","preferredDefinition":"ADENOCARCINOMA/ACINAR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B052-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662E1C-9A32-40FF-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Adenosquamous carcinoma","valueDescription":"ADENOSQUAMOUS CARCINOMA","ValueMeaning":{"publicId":"2558186","version":"1","preferredName":"ADENOSQUAMOUS CARCINOMA","longName":"2558186v1.00","preferredDefinition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662E1C-9A35-40FF-E034-0003BA12F5E7","beginDate":"2002-08-05","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Basaloid and adenoid cystic carcinoma","valueDescription":"BASALOID AND ADENOID CYSTIC CARCINOMA","ValueMeaning":{"publicId":"2558273","version":"1","preferredName":"BASALOID AND ADENOID CYSTIC CARCINOMA","longName":"2558273","preferredDefinition":"BASALOID AND ADENOID CYSTIC CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0AE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662E1C-9A37-40FF-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Lymphoepithelioma-like carcinoma","valueDescription":"LYMPHOEPITHELIOMA-LIKE CARCINOMA","ValueMeaning":{"publicId":"2559130","version":"1","preferredName":"LYMPHOEPITHELIOMA-LIKE CARCINOMA","longName":"2559130","preferredDefinition":"LYMPHOEPITHELIOMA-LIKE CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoepithelioma-like Carcinoma","conceptCode":"C27387","definition":"Definition not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B407-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662E1C-9A3A-40FF-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD6631B3-8DCF-4101-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Mucinous (colloid) adenocarcinoma","valueDescription":"MUCINOUS (COLLOID) ADENOCARCINOMA","ValueMeaning":{"publicId":"2559282","version":"1","preferredName":"MUCINOUS (COLLOID) ADENOCARCINOMA","longName":"2559282","preferredDefinition":"MUCINOUS (COLLOID) ADENOCARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B49F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD6631B3-8DD1-4101-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Prostatic duct adenocarcinoma","valueDescription":"PROSTATIC DUCT ADENOCARCINOMA","ValueMeaning":{"publicId":"2559919","version":"1","preferredName":"PROSTATIC DUCT ADENOCARCINOMA","longName":"2559919","preferredDefinition":"PROSTATIC DUCT ADENOCARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B71C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD6631B3-8DD3-4101-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Sarcomatoid carcinoma","valueDescription":"Sarcomatoid carcinoma","ValueMeaning":{"publicId":"2574080","version":"1","preferredName":"Sarcomatoid carcinoma","longName":"2574080","preferredDefinition":"Sarcomatoid carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Carcinoma","conceptCode":"C27004","definition":"A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD6631B3-8DD6-4101-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Signet ring cell carcinoma","valueDescription":"SIGNET RING CELL CARCINOMA","ValueMeaning":{"publicId":"2560049","version":"1","preferredName":"SIGNET RING CELL CARCINOMA","longName":"2560049v1.00","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B79E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD6631B3-8DD9-4101-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Small cell carcinoma","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD663644-0796-43A2-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous cell carcinoma","ValueMeaning":{"publicId":"2574081","version":"1","preferredName":"Squamous cell carcinoma","longName":"2574081","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD663644-0798-43A2-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Transitional cell carcinoma","valueDescription":"Transitional Cell Carcinoma","ValueMeaning":{"publicId":"2560303","version":"1","preferredName":"Transitional Cell Carcinoma","longName":"2560303","preferredDefinition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transitional Cell Carcinoma","conceptCode":"C2930","definition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B89C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD663644-079A-43A2-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma NOS","valueDescription":"UNDIFFERENTIATED CARCINOMA, NOT OTHERWISE SPECIFIED","ValueMeaning":{"publicId":"2560394","version":"1","preferredName":"UNDIFFERENTIATED CARCINOMA, NOT OTHERWISE SPECIFIED","longName":"2560394","preferredDefinition":"UNDIFFERENTIATED CARCINOMA, NOT OTHERWISE SPECIFIED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD663644-079E-43A2-E034-0003BA12F5E7","beginDate":"2004-06-21","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Urothelial primary in prostate","valueDescription":"UROTHELIAL PRIMARY IN PROSTATE","ValueMeaning":{"publicId":"2560416","version":"1","preferredName":"UROTHELIAL PRIMARY IN PROSTATE","longName":"2560416","preferredDefinition":"UROTHELIAL PRIMARY IN PROSTATE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B90D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD663644-07A1-43A2-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F869A4D-AEE3-0631-E044-0003BA3F9857","beginDate":"2006-03-21","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-21","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4344943-6204-0EF9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-14","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-14","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"6/21 - values added that were omitted during update for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811916","version":"1","longName":"Localized Prostate","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"},{"publicId":"2811937","version":"1","longName":"Pathology Prostate","context":"CTEP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"},{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"PRS_TUMOR_HIST_CAT","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Histologic Type","url":null,"context":"CTEP"},{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B4346762-5496-0F01-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-14","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-14","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":"ISO 11179 Compliance; values added that were omitted during update for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}